Fundraising Fox

John Kollins

Chief Executive Officer at Respira

San Francisco, California, United States

Find your path to John

14 people in our graph share verified history with John — schools, employers, funds. One of them is your warm intro.

Jake NunnunlockedJohn: together at Transcept Pharmaceuticals, Inc. (2012–2014)
×2John: together at Parnassus Advisors, LLC and Locust Walk Partners, LLC
John: together at CovX
×2John: together at Satsuma Pharmaceuticals, Inc.

Chief Executive Officer at Respira

Intro paths

→

In turn, John can intro founders to Respira's investors below.

Respira's investors · 4

Cottonwood Technology FundDenver · $1M – $25M checksNational Institutes of Health (NIH)since 2019Samsara BioCapitalPalo AltoZentynel Frontier InvestmentsSantiago · since 2022

Experience

  1. Respira Therapeutics, Inc.CEO and Corporate Directorcurrent2024 — presentSan Francisco Bay Area
  2. Cyrano TherapeuticsCorporate Directorcurrent2021 — present
  3. Satsuma Pharmaceuticals, Inc.Cofounder, CEO, President and Corporate Director2016 — 2023South San Francisco, CA
  4. Transcept Pharmaceuticals, Inc.Chief Business Officer & Senior Vice President2012 — 2014Point Richmond, CA
  5. Parnassus Advisors, LLC and Locust Walk Partners, LLCManaging Director2009 — 2012San Francisco, CA
  6. OXiGENE, Inc.CEO and Corporate Director2007 — 2009
  7. CovXChief Business Officer / Advisory Board Chair2004 — 2008San Diego, CA
  8. Healthcare investment fund and biopharmaceutical companiesConsulting Executive2005 — 2007
  9. RenovisVice President, Business Development2003 — 2004
  10. SurroMedVice President, Business Development2000 — 2003
  11. Athena Neurosciences & Elan PharmaceuticalsBusiness Development and Product Management roles1994 — 1999
  12. Immunex CorporationProduct Manager1989 — 1993

Skills & more

BiotechnologyPharmaceutical IndustryLifesciencesBiopharmaceuticalsStrategyBusiness DevelopmentCorporate DevelopmentFundraisingMergers & AcquisitionsStrategic PartnershipsLicensingDeal Execution
+12 moreCapital RaisingCommercializationStart-upsGeneral ManagementOpportunity AssessmentValue PropositionsOncologyClinical DevelopmentCRODrug DevelopmentDrug DiscoveryTechnology Transfer

From John's professional profile.

Frequently asked questions

Who is John Kollins?
Chief Executive Officer at Respira
Where does John Kollins work?
John Kollins is Chief Executive Officer at Respira.
Where did John Kollins go to school?
John Kollins studied at University of Virginia Darden School of Business (Master of Business Administration - MBA, General Management); Duke University Pratt School of Engineering (Bachelor of Science in Engineering, Mechanical Engineering and Materials Science).

Same school

Also attended University of Virginia Darden School of Business237

Cathy FriedmanInvestor at GV (Google Ventures)Dan LynchInvestor at GV (Google Ventures)Rajan MehraPartner at March Capital PartnersRob LudwigChief Operating Officer at Hoxton VenturesMatt BolanderBusiness Operations Associate at QED InvestorsJennifer SchretterGeneral Partner - Secondaries at PROOF

+ 231 more

Also attended Duke University Pratt School of Engineering5

Nicholas AllenSenior Associate at Duke Capital PartnersChristine ParkFounder at Lattice HealthNick LockettFounder at Pear SuiteBRADLEY JACOBSFOUNDER at MylanceTom RomaryFounder and CEO at Biztrip

Shared employers

Also worked at Cyrano Therapeutics2

Gerry BrunkManaging Director at Lumira VenturesRick GordonFounder at Tidal

Also worked at Satsuma Pharmaceuticals, Inc.3

Heath LukatchPartner at Novo HoldingsThomas B KingExecutive Officer, Director at Alexza PharmaceuticalsTom O'NeilChief Financial Officer at Satsuma Pharmaceuticals

Also worked at Parnassus Advisors, LLC and Locust Walk Partners, LLC8

David PrimPrincipal at Broadview VenturesKuan YuSenior Analyst at NYBC VenturesRoss LeimbergFounder / EIR at 82VSSamantha YoungAdvisor - Finance at Kicker VenturesEric WeiAssociate, Structured Capital at RA CapitalRob BaldoniFounder at Dannce AI

+ 2 more

Also worked at Renovis1

Hong WanExecutive Officer, Director at Tallac Therapeutics